DECEASED DONOR KIDNEY TRANSPLANT

Clinical trials for DECEASED DONOR KIDNEY TRANSPLANT explained in plain language.

Never miss a new study

Get alerted when new DECEASED DONOR KIDNEY TRANSPLANT trials appear

Sign up with your email to follow new studies for DECEASED DONOR KIDNEY TRANSPLANT, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Trials to join now! 1 Not yet finished but already full! 1

New hope for kidney transplant patients: drug aims to prevent early organ failure

Disease control Recruiting now

This study is testing whether an investigational drug called pegcetacoplan can help prevent a common complication called delayed graft function (DGF) after a kidney transplant. DGF means the new kidney doesn't work right away, often requiring temporary dialysis. The trial will en…

Matched conditions: DECEASED DONOR KIDNEY TRANSPLANT

Phase: PHASE3 • Sponsor: Apellis Pharmaceuticals, Inc. • Aim: Disease control

Last updated Apr 01, 2026 14:41 UTC

DECEASED DONOR KIDNEY TRANSPLANT

Get alerted when new DECEASED DONOR KIDNEY TRANSPLANT trials appear

New hope for kidney transplant patients: drug aims to prevent early organ failure